PERSPECTA

News from every angle

← Back to headlines

Experts estimate this US biotech stock has 100 percent potential, one even 250 percent [premium]

Developers of medical active ingredients often have a long road ahead until a preparation is approved. This company has several in the pipeline.

7 Mar, 16:35 — 7 Mar, 16:35
PostShare

Sources

Showing 1 of 2 sources
YahooMostly Factual155d ago

Where Will Eli Lilly Stock Be in 10 Years?

Read full article →

Coverage Timeline

First report: die-presse · 7 Mar, 15:03Full coverage: 2 · 2hWindow: 2h
Left-leaningCenterRight-leaning
die-presse7 Mar, 15:03First to report

Dieser US-Biotechaktie trauen Experten im Schnitt 100 Prozent Kurspotenzial zu, einer sogar 250 Prozent [premium]

2h later
Yahoo7 Mar, 16:35Latest update

Where Will Eli Lilly Stock Be in 10 Years?

Related Stories

Retirees Can Withdraw Up To $47,500 From IRAs Tax-Free

4h ago

Powerball Jackpot Winning Numbers Announced

8h ago

Choosing the Right Index Fund: Hallgeir Kvadsheim's Advice

11h ago

Best Time for Autumn Holidays: Two Months Financially Favorable

11h ago